News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
636,831 Results
Type
Article (20283)
Company Profile (202)
Press Release (616338)
Multimedia
Podcasts (55)
Webinars (13)
Section
Business (211432)
Career Advice (719)
Deals (31887)
Drug Delivery (50)
Drug Development (64221)
Employer Resources (57)
FDA (13388)
Job Trends (11700)
News (299684)
Policy (23121)
Tag
2027 BioCapital Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (4)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (5)
Academia (1518)
Accelerated approval (32)
ADA (26)
Adcomms (2)
Allergies (161)
Alliances (47191)
ALS (148)
Alzheimer's disease (1296)
Antibody-drug conjugate (ADC) (414)
Approvals (14110)
Artificial intelligence (711)
ASCO (204)
Autoimmune disease (279)
Automation (61)
Bankruptcy (298)
Best Places to Work (9350)
BIO (51)
BIOSECURE Act (7)
Biosimilars (137)
BioSpace Insights (96)
Biotechnology (137)
Bladder cancer (170)
Brain cancer (50)
Breast cancer (633)
Cancer (4938)
Cardiovascular disease (326)
Career advice (638)
Career pathing (13)
CAR-T (313)
CDC (12)
Celiac Disease (1)
Cell therapy (816)
Cervical cancer (46)
Clinical research (57071)
Collaboration (2071)
Commercialization (3)
Company closure (1)
Compensation (1500)
Complete response letters (41)
COVID-19 (1507)
CRISPR (118)
C-suite (1101)
Cystic fibrosis (114)
Data (7177)
Decentralized trials (2)
Denatured (28)
Depression (123)
Dermatology (76)
Diabetes (456)
Diagnostics (6571)
Digital health (65)
Diversity (7)
Diversity, equity & inclusion (13)
Drug discovery (314)
Drug pricing (24)
Drug shortages (7)
Duchenne muscular dystrophy (201)
Earnings (84651)
Editorial (11)
Employer branding (9)
Employer resources (54)
Events (108503)
Executive appointments (1012)
FDA (16969)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (19)
Frontotemporal dementia (29)
Funding (1568)
Gene editing (244)
Generative AI (53)
Gene therapy (581)
GLP-1 (501)
Government (1843)
Grass and pollen (4)
Guidances (356)
Healthcare (14456)
Hematology (123)
HIV (71)
Huntington's disease (28)
IgA nephropathy (78)
Immunology and inflammation (140)
Immuno-oncology (72)
Indications (195)
Infectious disease (1790)
Inflammatory bowel disease (161)
Inflation Reduction Act (6)
Influenza (126)
Intellectual property (313)
Interviews (87)
IPO (14985)
IRA (10)
Job creations (2764)
Job search strategy (573)
JPM (22)
Kidney cancer (19)
Labor market (27)
Layoffs (177)
Leadership (8)
Legal (6047)
Licensing (8)
Liver cancer (72)
Longevity (28)
Lung cancer (610)
Lymphoma (347)
Machine learning (56)
Management (20)
Manufacturing (964)
Marketing (10)
MASH (141)
Medical device (13699)
Medtech (13929)
Mergers & acquisitions (18228)
Metabolic disorders (939)
mRNA (194)
Multiple sclerosis (137)
NASH (7)
Neurodegenerative disease (336)
Neuropsychiatric disorders (53)
Neuroscience (2477)
NextGen: Class of 2026 (5064)
Non-profit (2035)
Now hiring (20)
Obesity (306)
Opinion (118)
Ovarian cancer (192)
Pain (210)
Pancreatic cancer (277)
Parkinson's disease (302)
Partnered (26)
Patents (600)
Patient recruitment (692)
Peanut (62)
People (53231)
Pharmaceutical (41)
Pharmacy benefit managers (12)
Phase 1 (18975)
Phase 2 (25436)
Phase 3 (17188)
Pipeline (9378)
Policy (80)
Postmarket research (1731)
Preclinical (8186)
Press Release (69)
Prostate cancer (271)
Psychedelics (10)
Radiopharmaceuticals (316)
Rare diseases (776)
Real estate (4886)
Recruiting (25)
Regulatory (19546)
Reports (26)
Research institute (1588)
Resumes & cover letters (111)
Rett syndrome (47)
RNA editing (19)
RSV (66)
Schizophrenia (117)
Series A (278)
Series B (198)
Service/supplier (6)
Sickle cell disease (76)
Special edition (1)
Spinal muscular atrophy (106)
Sponsored (25)
Startups (3311)
State (2)
Stomach cancer (4)
Supply chain (80)
Tariffs (12)
The Weekly (25)
Vaccines (705)
Venture capital (67)
Weight loss (114)
Women's health (106)
Worklife (4)
Date
Today (128)
Last 7 days (557)
Last 30 days (2130)
Last 365 days (25205)
2026 (16077)
2025 (25192)
2024 (30116)
2023 (34738)
2022 (45181)
2021 (48698)
2020 (45607)
2019 (36329)
2018 (27260)
2017 (27201)
2016 (26235)
2015 (32734)
2014 (27762)
2013 (23755)
2012 (25707)
2011 (26034)
2010 (24912)
Location
Africa (451)
Alabama (88)
Alaska (6)
Arizona (356)
Arkansas (16)
Asia (33566)
Australia (5237)
California (13562)
Canada (3698)
China (1093)
Colorado (595)
Connecticut (533)
Delaware (301)
Europe (64003)
Florida (2050)
Georgia (438)
Hawaii (4)
Idaho (60)
Illinois (1024)
India (85)
Indiana (442)
Iowa (21)
Japan (578)
Kansas (127)
Kentucky (46)
Louisiana (41)
Maine (39)
Maryland (1507)
Massachusetts (9511)
Michigan (399)
Minnesota (751)
Mississippi (6)
Missouri (145)
Montana (31)
Nebraska (19)
Nevada (129)
New Hampshire (89)
New Jersey (3175)
New Mexico (26)
New York (3443)
North Carolina (1647)
North Dakota (10)
Northern California (6743)
Ohio (384)
Oklahoma (23)
Oregon (28)
Pennsylvania (2604)
Puerto Rico (26)
Rhode Island (50)
South America (728)
South Carolina (90)
South Dakota (1)
Southern California (5571)
Tennessee (196)
Texas (2231)
United States (46513)
Utah (424)
Vermont (2)
Virginia (237)
Washington D.C. (52)
Washington State (1094)
West Virginia (3)
Wisconsin (144)
Wyoming (1)
636,831 Results for "siga technologies inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
SIGA Reports Financial Results for Three and Six Months Ended June 30, 2026
August 7, 2026
·
9 min read
Press Releases
SIGA to Host Business Update Call on August 6, 2026, Following Release of Second-Quarter 2026 Financial Results
July 30, 2026
·
1 min read
Press Releases
SIGA Reports Financial Results for Three Months Ended March 31, 2026 and Provides Business Update
May 8, 2026
·
9 min read
Press Releases
SIGA to Host Business Update Call on May 7, 2026, Following Release of First-Quarter 2026 Financial Results
April 30, 2026
·
1 min read
Press Releases
SIGA to Host Business Update Call on March 10, 2026, Following Release of 2025 Financial Results
March 3, 2026
·
1 min read
Press Releases
SIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2025 and Provides Business Update
March 11, 2026
·
11 min read
Press Releases
SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2025
November 6, 2025
·
10 min read
Press Releases
SIGA to Host Business Update Call on November 6, 2025 Following Release of Third-Quarter 2025 Results
October 31, 2025
·
1 min read
Business
SIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2023
SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today reported financial results for the three and twelve months ended December 31, 2023.
March 12, 2024
·
12 min read
Business
SIGA Names Larry Miller General Counsel
SIGA Technologies, Inc., a commercial-stage pharmaceutical company focused on health security and infectious diseases, announced the appointment of Larry Miller as general counsel.
March 25, 2024
·
7 min read
1 of 63,684
Next
